Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen, Sys Stybe Johansen, Sczabolz Lehel, Kristían Línnet, Claus Svarer, David Erritzøe, Brice Ozenne, Gitte M. Knudsen
Neuropsychopharmacology March 8, 2019 correction DOI: 10.1038/s41386-019-0360-5 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Topics | Psilocybin Serotonin |
|---|---|
| Keywords | Hallucinogen Pharmacology |
| Citations | 21 |
Abstract
The original version of this article contained an error in the labelling of Figures 2 and 3. While the captions and figures themselves are correct, in order to correspond with the in-text references, they have now been re-numbered in both the PDF and HTML versions of the article.
Citations in the library
Cited by 18
- Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists. ACS Chemical Neuroscience May 6, 2020
- Molecular and Medical Aspects of Psychedelics International Journal of Molecular Sciences December 23, 2023
- Preclinical models for evaluating psychedelics in the treatment of major depressive disorder. British Journal of Pharmacology October 28, 2024
- Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom ( Psilocybe cubensis ): A Systematic Review Journal of Psychoactive Drugs September 10, 2024
- Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice The International Journal of Neuropsychopharmacology May 25, 2025
and 13 more in the library